Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial

Introduction  This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of treatment with rivaroxaban or a vitamin-K antagonist (...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:TH Open
Egile Nagusiak: Kirchhof, Paulus, Ezekowitz, Michael D., Purmah, Yanish, Schiffer, Sonja, Meng, Isabelle L., Camm, A. John, Hohnloser, Stefan H., Schulz, Anke, Wosnitza, Melanie, Cappato, Riccardo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Georg Thieme Verlag KG 2020
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6978177/
https://ncbi.nlm.nih.gov/pubmed/31984306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1701206
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak